Search clinical trials for: Erythropoiesis stimulating agent (ESA)

Total 189747 results

Rennes University Hospital

Completed

Therapeutic Education of Chronic Renal or Renal Transplant Patient in the Management of EPO Injections (SELFEPO)

Renal Insufficiency, Chronic | Organ Graft

France
Mahidol University

Completed

The Effect of Mobilization With Movement in Individuals With Shoulder Impingement Syndrome (SIS)

Subacromial Impingement Syndrome | Shoulder Impingement Syndrome | Subacromial Pain Syndrome | Subacromial Impingement | Impingement Syndrome, Shoulder

Indonesia
Abbott Diagnostics Division

Completed

Abbott ESA Chagas Assay Post-Market Study (ESA)

Chagas Disease

United States
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis

Anemia | Dialysis | Chronic Renal Failure

China
Western Health, Australia

Completed

Study of the Effect of Synchronised Anaemia Management in Chronic Kidney Disease (EMAN-Anaemia)

Anemia | Kidney Failure, Chronic

Australia
Hoffmann-La Roche

Completed

Survey on Anemia Therapy in Participants With Chronic Kidney Disease (CKD) Not on Dialysis

Chronic Kidney Diseases

Israel
University of Louisville
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Intelligent Control Approach to Anemia Management

End-Stage Renal Disease

United States
Icahn School of Medicine at Mount Sinai
University of Florida; Florida International University; Citrus Health Network...

Completed

Impact of Clinician Virtual Human Interaction Training in Emotional Self-Awareness on Patients Suicidal Ideation and Suicide Crisis Syndrome

Suicide

United States
Hamid Al-Essa Organ Transplant Center

Completed

Impact of Full Correction of PTA in Renal Transplant Recipients

Anemia
University Hospital, Basel, Switzerland
Roche Pharma AG

Completed

Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)

Renal Anemia

Switzerland
Pfizer

Completed

A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin (AiME - 03)

Chronic Renal Failure Requiring Hemodialysis

United States, Puerto Rico
Sandoz

Completed

HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD) (SENSE)

Chronic Kidney Disease

Russian Federation, Germany, Italy, Poland, Romania, Turkey, Ukraine
University Hospital, Caen

Unknown

Influence of Gravity on the Size-mass Illusion (Massper)

Healthy

France
University of Bologna

Completed

Quality of Life After Surgery for End-stage Achalasia

Quality of Life | Symptoms and Signs

Italy
Giovanni FM Strippoli, MD

Completed

The Clinical Evaluation of the Dose of Erythropoietins Trial (CEDOSE)

Kidney Failure, Chronic

Italy
Bio Sidus SA
IC RESEARCH GROUP

Completed

Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia

Antineoplastic Chemotherapy Induced Anemia

Argentina
Association pour la recherche sur les Affections...

Completed

Biological Predictive Factors of Response to ESA in Low Risk MDS Patients

Myelodysplastic Syndromes
GlaxoSmithKline

Completed

Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents

Anaemia

Japan
Akebia Therapeutics

Completed

Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects

Anemia Associated With Chronic Kidney Disease (CKD)

United States
GlaxoSmithKline

Completed

Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis

Russian Federation
Astellas Pharma Inc
FibroGen

Completed

A Study of Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia

ESA-naive Hemodialysis Chronic Kidney Disease Patients With Anemia

Japan
Groupe Francophone des Myelodysplasies
Celgene

Recruiting

Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA

Myelodysplastic Syndromes | MDS

France
Helwan University

Completed

Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients

Anemia of Chronic Kidney Disease | Chronic Renal Failure | Chronic Renal Failure Anemia

Egypt
Hospices Civils de Lyon

Unknown

Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy (EPREX/LAM-ALLO)

Acute Myeloid Leukemia | Anemia

France
Pfizer

Completed

A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin (AiME - 04)

Chronic Renal Failure Requiring Hemodialysis

United States
Samuel Lunenfeld Research Institute, Mount Sinai...
Heart and Stroke Foundation of Ontario

Completed

Self-monitoring of Blood Pressure in Primary Care

High Blood Pressure

Canada
GlaxoSmithKline
Quintiles, Inc.; ERT: Clinical Trial Technology Solutions; Q2 Solutions; HemoCue

Completed

Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)

Anaemia

United States
Charite University, Berlin, Germany

Completed

Helsinki Declaration on Patient Safety (Patient Safety)

Patient Safety

Germany
Kaohsiung Medical University Chung-Ho Memorial...

Completed

A Model of Computer-assisted Prescription of Erythropoiesis-stimulating Agents (ESA) in Patients Under Hemodialysis

End Stage Renal Disease

Taiwan
Johnson & Johnson Pharmaceutical Research & Development...
Ortho Biotech Clinical Affairs, L.L.C.

Completed

A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.

Anemia | Renal Failure , Chronic
Ruijin Hospital

Not yet recruiting

PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma (ENKTL)

NK-T-Cell Lymphoma, Extranodal

China
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Finland, Australia, Spain, Italy, Canada, Czechia
Affymax
Takeda

Completed

Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA

Anemia | Chronic Kidney Disease | Chronic Renal Failure

Russian Federation
University of Pittsburgh
National Institute on Minority Health and Health Disparities (NIMHD)

Recruiting

Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial (HHD)

Cardiovascular Diseases | Vascular Diseases | Toxemia | Hypertension | Obesity | Nutrition Disorders | Overweight | Pregnancy Complications | Eclampsia | Pre-Eclampsia | Hypertension, Pregnancy-Induced | Preeclampsia | Hypertensive Disorder of Pregnancy | Gestational Hypertension

United States
Chulalongkorn University
Ministry of Health, Thailand

Unknown

A Prospective, Immunogenicity Surveillance Registry of Erythropoiesis Stimulating Agent (ESA) With Subcutaneous Exposure in Thailand

Erythropoietin
Ottawa Hospital Research Institute
Heart and Stroke Foundation of Ontario

Completed

Perioperative Myocardial Ischemia in Isolated Systolic Hypertension (PROMISE)

Myocardial Ischemia | Hypertension

Canada
Vifor Fresenius Medical Care Renal Pharma
Worldwide Clinical Trials; Fresenius Medical Care Deutschland GmbH

Terminated

Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial (ANEMEX)

Anemia | End Stage Renal Disease

United Kingdom
Rush University Medical Center

Recruiting

Endoscopic Size Assessment of Advanced Adenomatous Polyps

Adenoma Detection Rate Improvement in Screening Colonoscopy

United States
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

Hepatitis B | Measles | Pertussis | Rubella | Mumps | Tetanus | Diphtheria | Varicella | Poliomyelitis | Haemophilus Infections

Germany, Italy
Saint-Joseph University

Terminated

Erythropoietin Role in Acute Kidney Injury (EAKI)

Anemia Renal

Lebanon
Kyungpook National University Hospital
Roche Pharma AG; Fresenius Medical Care North America

Completed

Impact of Dialysis Modality on Hepcidin and Iron Metabolism (HERMES)

End-stage Renal Disease

Korea, Republic of
GlaxoSmithKline

Terminated

Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Neisseria Meningitidis | Haemophilus Influenzae Type b

Slovakia
NephroCare Spain
Francesc Moreso

Unknown

Assesment of a Predictive Model Dosage of EPO in Hemodialysis Patients

Anemia

Spain
Karolinska Institutet
Danderyd Hospital

Recruiting

Excessive Supraventricular Activity and Atrial Fibrillation (ESA-AF)

Atrial Fibrillation | Atrial Flutter | Supraventricular Beat, Premature | Premature Supraventricular Beats | Premature Atrial Complex | Extrasystole, Atrial

Sweden
Novartis Pharmaceuticals

Terminated

LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS) (GEPARD)

Myelodysplastic Syndrome (MDS)

Germany
TME Pharma AG

Completed

Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients

Anemia | End Stage Renal Disease

United Kingdom, Germany, Italy
FibroGen
AstraZeneca

Completed

Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants

Anemia Associated With End Stage Renal Disease (ESRD)

United States
Ruijin Hospital

Active, not recruiting

MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma

Extranodal NK/T-cell Lymphoma, Nasal Type

China
Brno University Hospital
European Society of Anaesthesiology (ESA)

Completed

Rapid Sequence Induction EU: Electronic Survey (RSIEU) (RSIEU)

Rapid Sequence Induction

Czechia
Rockwell Medical Technologies, Inc.

Completed

Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (PRIME)

End Stage Renal Disease

United States, Puerto Rico

Search clinical trials for: Erythropoiesis stimulating agent (ESA)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations